Top 50 Life Science VC Funds & Investors in Spain (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
8 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $155k–$19M |
|
Bullnet Capital
VC Fund
|
7 | Spain, United States, Mexico | Seed, Series A | Software, Information Technology, Manufacturing | $590k–$11M |
|
Capital Cell
VC Fund
|
6 | Spain, France, United States | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | $137k–$1.9M |
|
Asabys Partners
VC Fund
|
5 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$135M |
|
ENISA
VC Fund
|
4 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$2.2M |
|
Ysios Capital
VC Fund
|
3 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.2M–$135M |
|
Inveready
VC Fund
|
3 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $400k–$14M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
3 | Spain, Switzerland | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $266k–$16M |
|
Alta Life Sciences
VC Fund
|
3 | Spain, United States | Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical Device | $3M–$33M |
|
Invivo Capital Partners
VC Fund
|
3 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$71M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$37M |
|
Clave Capital
VC Fund
|
2 | Spain, Chile, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $527k–$16M |
|
Criteria Venture Tech
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Switzerland | Seed, Series A | Artificial Intelligence, FinTech, Software | $375k–$100M |
|
Fund+
VC Fund
|
2 | Belgium, United States, Spain | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$401M |
|
Criteria Bio Ventures
VC Fund
|
2 | United Kingdom, Spain | Seed, Pre-Seed, Series A | Biotechnology, Life Science, Medical | $3.5M–$83M |
|
Nara Capital
VC Fund
|
2 | Spain | Seed, Series A | Life Science, Biotechnology, Medical | $394k–$7.4M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $274k–$41M |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology | $3.4M–$7.4M |
|
Amadeus Capital Partners
VC Fund
|
2 | United Kingdom, United States, Spain | Series B, Seed, Series A | Software, Artificial Intelligence, Information Technology | $900k–$43M |
|
Xesgalicia
VC Fund
|
2 | Spain, Portugal | Seed, Pre-Seed | Software, Biotechnology, Pharmaceutical | $304k–$5.9M |
|
BStartup
VC Fund
|
2 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.2M |
|
Charme Capital Partners
VC Fund
|
2 | Spain | Series A | Genetics, Life Science, Biotechnology | $5.5M–$20M |
|
Speedinvest
VC Fund
|
2 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $549k–$38M |
|
Talis Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Information Technology, E-Commerce | $1M–$30M |
|
BeAble Capital
VC Fund
|
2 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
Demium Capital
VC Fund
|
2 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, FinTech, Health Care | $110k–$3.1M |
|
Ezten Venture Capital Fund
VC Fund
|
1 | Spain | Seed | Software, Automotive, Clean Energy | |
|
European Investment Bank
VC Fund
|
1 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | |
|
Reig Jofre
VC Fund
|
1 | Spain | Medical, Biopharma, Life Science | ||
|
Grow Venture Partners
VC Fund
|
1 | Spain | Pre-Seed, Seed | Health Care, Artificial Intelligence, Biotechnology | |
|
BCN PEPTIDES
VC Fund
|
1 | Spain | Medical, Biopharma, Life Science | ||
|
CDTI
VC Fund
|
1 | Spain, United States, Mexico | Seed, Debt Financing | Software, Information Technology, Health Care | |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
SeedBlink
VC Fund
|
1 | Romania, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | |
|
Santander
VC Fund
|
1 | United Kingdom, Spain, United States | Debt Financing, Post-IPO Debt, Seed | Energy, Renewable Energy, Financial Services | $100k–$1.5B |
|
Veg Capital
VC Fund
|
1 | United Kingdom, Brazil, Sweden | Seed, Equity Crowdfunding, Pre-Seed | Food and Beverage, Biotechnology, Food Processing | $271k–$8.1M |
|
Grupo Ferrer Internacional
VC Fund
|
1 | Spain | Series A | Biotechnology, Wellness, Biopharma | |
|
BAGi
VC Fund
|
1 | Spain, Norway, Switzerland | Seed, Angel | Internet, Health Care, Software | $219k–$690k |
|
ProVeg International
VC Fund
|
1 | Germany, China, Spain | Seed, Pre-Seed, Series A | Food and Beverage, Food Processing, Nutrition | $589k–$2.4M |
|
Addition
VC Fund
|
1 | United States, India, Brazil | Series A, Series B, Series C | Software, FinTech, Financial Services | |
|
Alma Mundi Ventures
VC Fund
|
1 | Spain, United States, United Kingdom | Series A, Seed | Software, Insurance, InsurTech | |
|
Inveniam
VC Fund
|
1 | Spain | Seed | Biopharma, Health Care, Life Science | |
|
Fides Capital
VC Fund
|
1 | Spain | Seed, Pre-Seed, Series A | Software, Automotive, Telecommunications | |
|
ICF Capital
VC Fund
|
1 | Spain, United States, Mexico | Debt Financing, Seed | Software, Biotechnology, Health Care | |
|
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund
|
1 | Spain | Pre-Seed, Series A | Apps, Big Data, Aerospace | |
|
Innova-Tech Consulting
VC Fund
|
1 | Canada, Spain | Series A, Seed, Series B | Solar, Energy, Medical | $1.8M–$16M |
|
Clave Mayor
VC Fund
|
1 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
Debiopharm Innovation Fund
VC Fund
|
1 | Switzerland, United States, France | Series A, Seed, Pre-Seed | Health Care, Biotechnology, Software | $943k–$25M |
|
Catalan Institution for Research and Advanced Studies
VC Fund
|
1 | Spain | Seed | Life Science, Biotechnology | |
| Access all 121 VC funds in Spain Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 184
- Round size: Seed $562k–$5.9M; Grant $155k–$19M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- TetraxAI — TetraxAI helps renewable energy developers and investors automate due diligence and risk assessment - 100x faster, 10x cheaper, with full legal traceability.
- Golden Owl —
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 60
- Round size: Seed $1M–$3.3M; Series A $590k–$11M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — FlexiiC is a deep-tech firm developing printed, flexible integrated circuits for sustainable IoT and smart packaging solutions.
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues and cells. We are focusing the application of our technology in fields like Mechanobiology where the study of diseases directly related with cell migration or development are demanding new techniques. We offer cutting-edge non-invasive to...
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, France, United States
Investor stats
- Total investments: 51
- Round size: Seed $384k–$1.9M; Equity Crowdfunding $137k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- EVerZom — EVerZom is an exosome biotech company developing exosome therapeutics in digestive tissue healing, fistula and organ regeneration.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- EVis Bioscience — EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 36
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $19M–$135M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
- INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 189
- Round size: Seed $76k–$2.2M; Pre-Seed $186k–$1.2M; Debt Financing $66k–$494k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Swipoo — Transferencia de vehículos y cambio de nombre automatizado.
- TucanPay — TucanPay is a money transfer platform that sends money between continents.
- DARWIN Biomed — Biomedical Engineering
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 79
- Round size: Series A $2.2M–$63M; Series B $17M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Cytoki Pharma — Cytoki Pharma is a biotechnology company developing a portfolio of IL-22-based drugs as a new treatment paradigm for serious diseases involving epithelial injury.
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 156
- Round size: Seed $400k–$5.5M; Series A $1.6M–$14M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Qbeast Analytics — Qbeast Analytics SL is a spin-off of the Barcelona Supercomputing Center (BSC). Qbeast is a Big Data cloud platform with a patented data storage technology that reorganizes and manages data through multidimensional indexing and sampling techniques so that it can be analyzed up to 100 times faster. Qbeast provides data teams with the option toadjust the precision of data analytics to produce high-quality insights while only accessing a fraction of the available data. This speeds up their work massively and at the same time produces savings on computational resources and energy.
- StereoDive —
- 53Biologics — More than 98% of proteins in its hands have improved their production and/or recovery yields. Contact us to explore how can we help you
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 46
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Zoundream — The Future of Infant Care
- Nanoligent — Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Venture - Series Unknown
- Geography: Spain, United States
Investor stats
- Total investments: 17
- Round size: Series A $3M–$33M; Venture - Series Unknown $5.8M–$12M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 24
- Round size: Seed $1.6M–$13M; Series A $2.2M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 44
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
- Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
- Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 40
- Round size: Seed $527k–$5.5M; Series A $4.9M–$16M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Innitius — AI-powered obstetric diagnostics for improved preterm birth risk assessment.
- Sincrolab — Descubre Sincrolab, el tratamiento digital que utiliza inteligencia artificial para mejorar los procesos cognitivos. Con eficacia validada en TDAH
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 150
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Scalestack — Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline.
- Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Artificial Intelligence, FinTech, Software
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $375k–$10M; Series A $1.3M–$100M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Klay — Reimagine music with KLAY.
- Shipsi — Shipsi empowers any retailer with the ability to offer an easy “instant shipping” option on their checkout page—without worrying about logistics. They use existing infrastructure and last-mile delivery networks to help customers order now AND get it now. Shipsi was founded in 2017 and is headquartered in Austin, TX.
- Scout AI — Scout AI is building the robotic foundation model for defense.
Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 31
- Round size: Series A $11M–$44M; Series B $21M–$125M; Series C $11M–$401M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Indigo Diabetes — Revolutionizing the management of chronic disease.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Supporting life-changing therapies through long-term strategic partnerships
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Spain
Investor stats
- Total investments: 6
- Round size: Pre-Seed $3.5M–$3.5M; Series A $30M–$83M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Tolerance Bio — Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
- AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
- Adaptam Therapeutics — Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.4M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $1.1M–$8.7M; Pre-Seed $274k–$2M; Series A $717k–$41M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
- Vivid Machines — Digitizing permanent crop production | Vivid Machines | Ontario
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Seed $3.4M–$7.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series B, Seed, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 234
- Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$43M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Pimloc — Pimloc's deep learning platform enables private businesses and public organisations to protect sensitive or personal data in video, to maintain safe online environments and to manage video security.
- XYZ Reality — XYZ Reality - The world's first Engineering-Grade augmented reality system for construction.
- Altana — Altana powers trusted trade for governments and businesses worldwide. Map supply chains, manage tariffs, ensure compliance, and build resilience with AI.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 33
- Round size: Seed $304k–$5.9M; Pre-Seed $439k–$2.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 81
- Round size: Seed $110k–$2.2M; Pre-Seed $110k–$2.2M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- TietAI — TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more...Investment focus
- Industry: Genetics, Life Science, Biotechnology
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Series A $5.5M–$20M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 527
- Round size: Seed $823k–$8M; Pre-Seed $549k–$3.8M; Series A $3.7M–$38M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Tulyp — Tulyp is a financial service company that offers insure, investment, and secure payment solutions.
- morgana — Morgana is reshaping the mortgage industry in Latam. With a 5x faster application process, in-depth market knowledge, privileged access to data, and superb team, we are a groundbreaking digital mortgage broker that will shortly be competing with banks.
- Sona — The employee 'super' app for frontline teams. Sona combines the power of modern workforce management software with an unparalleled mobile user experience.
We back founders who see the future differently.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 81
- Round size: Seed $1M–$13M; Series A $3M–$24M; Series B $10M–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- Beyond — Write your will online, apply for probate or arrange a meaningful funeral.
- IOTICS — We are changing how the world uses and shares data. Enabling secure, trusted data interactions for everything and everyone, in real-time, at scale. The challenge facing industries is one of access to, and security of, data. The problem isn't that the data doesn't exist it's that we can't securely access it where we need itwhen we need. System integrations, centralisation and point to point solutions are costly, duplicate date, and increase risk of failure.The solution is a secure ecosystem of data interactions, filtering what matters at source and channelling it to where it's needed. Data is not duplicated. Re-architecting is avoided as new sources/consumers added Secure data interactions minimise time to market, reduce costs and mitigate risk. Delivering value within a quarter.Our solution IOTICSpace, is cloud-hosted software, in which data becomes Findable Accessible, Interoperable and Reusable. Secure-by-design IOTICS creates a data mesh of sources and consumers of data using Digital Twins, virtual versions of anything (assets, data, algorithms). Delivering scalable building blocks for your data strategy, without locking you in to architectural choices.
- Clausematch — Our award-winning policy management, regulatory change management and compliance platform automates time-sucking tasks, organises your data and makes collaboration and knowledge-sharing a breeze. Learn more here
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 67
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$274k
- Lead/follow: 82% lead, 18% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Calpech — Calpech focuses on technology and innovation based on this description, here are a few potential characteristics and strengths.
- ALA Diagnostics — ALA Diagnostics develops and markets in vitro Diagnostic Kits for pathologies with high prevalence and/or unresolved medical needs, based on existing synergies with some of the Public Organizations with the greatest capacity to generate innovative projects.
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 83
- Round size: Seed $110k–$3.1M; Pre-Seed $110k–$450k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Qalea —
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- KomboAI — Supercharge your CRM and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. Book a Demo See Kombo in Action Over 1000+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right leads Receive every day new leads
Ezten Venture Capital Fund
Show more...Investment focus
- Industry: Software, Automotive, Clean Energy
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 271
- Lead/follow: no public data
Portfolio highlights
- Solynta — Welcome to the homepage of Solynta, leader in hybrid potato breeding and development of hybrid true potato seeds with attractive traits.
- Evaxion Biotech — Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currentlyincludes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus) induced skin and soft tissue infections.
- Electrica — Electrica is a holding company involved in projects connected to the provision of power to final consumers as well as the development and operation of electrical distribution networks. It primarily serves as the principal electricity supplier in and throughout the town as well as an electricity distribution operator. The following segments make upthe company's business: electricity and gas supply, which is involved in acquiring and providing electricity and gas to end users, electricity generation, which produces electricity, electricity distribution, which offers services related to electricity distribution, external electricity network services, which provides maintenance, repairs, and other services for electricity networks owned by other distributors, and electricity distribution.
Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.
Show more...Investment focus
- Industry: Medical, Biopharma, Life Science
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Pre-Seed, Seed
- Geography: Spain
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- SHINEPHI — Shinephi's vision is to change the state-of-the-art in nano-characterization and nano-fabrication to improve yield and expedite production in semiconductor manufacturing.
- Virtest Technologies — Virtest Technologies is an innovation firm focused on personalized medicine, providing computational models, simulations, and image processing solutions to aid surgeons and medical device companies in testing products, enhancing decision-making, and improving clinical outcomes.
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more...Investment focus
- Industry: Medical, Biopharma, Life Science
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Debt Financing
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 288
- Lead/follow: no public data
Portfolio highlights
- DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
- AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
- Excelsior Sciences — Rebuilding the World, From the Bottom Up
All-in-one solution for fundraising, managing and trading equity. Explore promising tech startups and flexible funding opportunities with SeedBlink.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Romania, United States, United Kingdom
Investor stats
- Total investments: 103
- Lead/follow: no public data
Portfolio highlights
- Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
- Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
- dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Financial Services
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: United Kingdom, Spain, United States
Investor stats
- Total investments: 124
- Round size: Seed $100k–$3.3M; Post-IPO Debt $14M–$1.5B; Debt Financing $16M–$1.5B
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $658M in 2019
Portfolio highlights
- Ebury — Ebury UK | The Latest Fintech & Finance Solutions
- InstaVolt — InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle.They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastestcharging available.They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions.Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution.According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country.They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.
- GreenYellow — Green Yellow Holding generates electricity from centralized power plants and offers solar panels. The company allows anyone to produce and manage energy while creating value, through solar photovoltaics, efficiency, and energy optimization. The company was founded in 2007 and is headquartered in France.
Veg Capital provides Angel, Seed, and Series A capital to companies striving to replace the use of animals in the food system. All profits go to charity.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United Kingdom, Brazil, Sweden
Investor stats
- Total investments: 21
- Round size: Seed $271k–$8.1M; Equity Crowdfunding $271k–$5.1M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Nutropy — Nutropy produces real milk ingredients, identical to those produced by cows, to develop premium cheese alternatives that taste just as good as cow’s cheese but are more sustainable, healthier and better for the animals. No animals involved, full cheese experience.
- Super Vegan — Loja de chocolates veganos
- SHICKEN Foods — Plant-based chicken manufacturer
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more...Investment focus
- Industry: Biotechnology, Wellness, Biopharma
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
- ABAC Therapeutics — Situs resmi di Indonesia yang menghadirkan game dari PG Soft & Pragmatic Play Paling Gacor , Gampang JP Disini, surga77 memberikan akses ke permainan slot berkualitas tinggi dengan RTP yang terbukti akurat. Semua game yang disediakan di situs ini memiliki tingkat kemenangan yang transparan dan mudah diprediksi. surga77 memastikan bahwa setiap permainan dioperasikan dengan standar tertinggi dalam hal keamanan dan keadilan. Dengan berbagai fitur menarik dan berbagai pilihan permainan, pemain dapat menikmati pengalaman bermain slot yang menyenangkan dan menguntungkan. Ditambah dengan sistem transaksi yang cepat dan layanan pelanggan yang responsif, surga77 adalah tempat yang sempurna untuk para penggemar slot di Indonesia yang ingin bermain dengan nyaman.
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more...Investment focus
- Industry: Internet, Health Care, Software
- Stage:Seed, Angel
- Geography: Spain, Norway, Switzerland
Investor stats
- Total investments: 8
- Round size: Seed $219k–$690k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
2025 has been a powerful step forward in accelerating the global shift towards more plant-based food systems. From influencing policy and supporting businesses, to reaching millions through campaigns and education, our work continues to grow in both scale and impact.Our 2025 Impact Report brings together the results of that collective effort.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Nutrition
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, China, Spain
Investor stats
- Total investments: 11
- Round size: Seed $589k–$2.4M; Pre-Seed $600k–$1.5M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Poseidona — We provide sustainable protein ingredients from seaweed side-streams and invasive algae so manufacturers can develop the tastiest food products.
- Quazy Foods — Quazy Foods unleashes the power of microalgae for healthy, sustainable, and competitive functional ingredients.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Series B, Series C
- Geography: United States, India, Brazil
Investor stats
- Total investments: 145
- Lead/follow: no public data
Portfolio highlights
- Render — Deploy and scale any app or agent from your first user to your billionth. Build faster on intuitive cloud infrastructure for the modern web.
- Ernesta — Made to fit your home. Ernesta offers designer quality custom-sized rugs that make you proud of the home you've designed. Shop now.
- Onehouse — Open storage, continuous pipelines, and automatic optimizations across table formats, engines, clouds. Automated data platform across Hudi, Delta, and Iceberg.
We back bold and purpose-driven founders.
Show more...Investment focus
- Industry: Software, Insurance, InsurTech
- Stage:Series A, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 108
- Lead/follow: no public data
Portfolio highlights
- LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
- Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Strategic consulting for meaningful innovations in health, sustainability and deep tech.
Show more...Investment focus
- Industry: Biopharma, Health Care, Life Science
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
- NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more...Investment focus
- Industry: Software, Automotive, Telecommunications
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 98
- Lead/follow: no public data
Portfolio highlights
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
- Harmonix — Harmonix is a software development company that uses AI for CRM to communicate with customers to send email, calls, and SMS.
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
CDTI
Show more...Investment focus
- Industry: Apps, Big Data, Aerospace
- Stage:Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Inspide — Understand all the information in the real world and make it actionable
- FYLA — At FYLA we create unique All-fiber Ultrafast pulsed lasers by Joining Singularity with Quality. Discover our multiphoton and two photon lasers!
- 2Eyes Vision — 2EyesVision is a start-up (CSIC spin-off) specialized in the creation, development, and commercialization of novel ophthalmic technologies.
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more...Investment focus
- Industry: Solar, Energy, Medical
- Stage:Series A, Seed, Series B
- Geography: Canada, Spain
Investor stats
- Total investments: 5
- Round size: Series A $1.8M–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Pre-Seed
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 37
- Round size: Seed $943k–$6M; Series A $3.5M–$25M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- Neuroute —
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
- VeriSIM Life — Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.
ICREA is a foundation supported by the Catalan Government for the advancement of research.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Life Science VC funding in Spain at a glance
Stats across 102 deals from 121 investors.
Access all 121 VC funds in Spain Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 121 VC funds investing in Spain Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!